Unternehmen wird geladen
Just reported
Q3 FY2027 results
From Kenvue's results release of 30. Oktober 2026; its quarterly report has since been filed.
Revenue
Actual
3,89B $
+3,2 % y/y
-1,7 % q/qGuided
—
No guide given
EPS, GAAP
Actual
0,22 $
+4,8 % y/y
-8,3 % q/qGuided
—
No guide given
Operating income, GAAP
Actual
706M $
+12 % y/y
+1,0 % q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Kenvue is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Household and Personal Products
Graded A or B and worth $2B or more: A first, then the largest.
PGProcter & Gamble Co393,6B $A+
CLColgate-Palmolive Company79,2B $A
ELFe.l.f. Beauty, Inc.7B $A
ELEstee Lauder Companies Inc40,5B $B
IPARInterparfums, Inc.4,3B $B+
Grade rose recently in Consumer Staples
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
BUDAnheuser-Busch InBev SA30. Juli 2026BAGraded B, now A
MDLZMondelez International, Inc.29. Okt. 2026CAGraded C, now A
HSYHershey Co.29. Okt. 2026BAGraded B, now A
SYYSysco Corporation4. Nov. 2026BAGraded B, now A- ELFe.l.f. Beauty, Inc.4. Nov. 2026BAGraded B, now A
Womit das Unternehmen Geld verdient
- Self Care43 %
- Essential Health31 %
- Skin Health and Beauty27 %
Die Umsatzanteile sind Schätzungen für quarter ended 2026-09-27 und keine Zahlen aus einem eingereichten Bericht.
Konkurriert mit
- HLNHaleon plcB
- Größe
- 41,1B $
- Marge
- 15,1 %
- PGThe Procter & Gamble CompanyA
- Größe
- 393,6B $
- Marge
- 18,2 %
- RBGLYReckitt Benckiser Group plc
- LRLCYL'Oréal S.A.
- ULUnilever PLCD
- Größe
- 144,4B $
- Marge
- 18,7 %
- CLColgate-Palmolive CompanyA
- Größe
- 79,2B $
- Marge
- 9,6 %
Was es verkauft6
Tylenol
Nonprescription medicines for pain and fever.
Zyrtec
Medicines for allergy symptoms.
Nicorette
Products to help people stop smoking.
3 weitere anzeigen
Neutrogena
Skin and hair care products, including face and body care.
Listerine
Mouthwash and other oral care products.
BAND-AID Brand
Adhesive bandages and other wound-care products.
Wer es kauft3
- Retailers and pharmacies buy branded products for resale in stores and through their online shops.
- Online retailers sell Kenvue products to consumers through e-commerce channels.
- Consumers buy the products through retail, pharmacy and online channels.
Worauf es steht, und was es umwerfen könnte
Wovon das Geschäft abhängt
- 1Kenvue relies on outside manufacturers for some products and on third-party operators for most of its distribution centers.
- 2It buys most raw and packaging materials from outside suppliers; some materials come from a single supplier or a limited number of suppliers, and commodity prices can change.
- 3Some legacy Johnson & Johnson names and branding, including Johnson’s, are used under licenses with varying durations.
Was schiefgehen könnte
- 1The pending combination with Kimberly-Clark depends on remaining regulatory approvals and other closing conditions; delay or failure to complete it could disrupt operations, customers, suppliers or employees.
- 2Product safety, ingredient or labeling concerns can lead to recalls, regulatory action, lawsuits and reputational harm; Kenvue also faces talc-related proceedings involving Johnson’s Baby Powder sold outside the United States and Canada.
- 3Competition from other brands and retailer-owned products, changing consumer preferences, and retailers’ ordering and inventory decisions can affect sales; Kenvue has also faced distribution losses in some product categories.
Über Kenvue Inc.
Its brands include Tylenol and Zyrtec medicines, Neutrogena skin and hair care, Listerine mouthwash, and BAND-AID wound-care products. It sells through retail and online channels around the world. Kenvue has a pending agreement to combine with Kimberly-Clark, subject to remaining conditions and regulatory approvals.
- Hauptsitz
- Summit, New Jersey, United States
- Gegründet
- 2022
- Beschäftigte
- approximately 22,000 (as of December 28, 2025, high)
- Notiert an
- NYSE
- Geschäftsjahresende
- December
Gebaut aus den eigenen Einreichungen von Kenvue Inc. bei der US-Börsenaufsicht Securities and Exchange Commission (SEC). Die Zahlen sind wie berichtet, die Historie je Aktie auf die heutige Aktienbasis umgerechnet. Dies beschreibt ein Unternehmen — es ist keine Anlageberatung und keine Kauf- oder Verkaufsempfehlung.
